Koa Shoji Holdings Co.,Ltd. (TYO:9273)
Japan · Delayed Price · Currency is JPY 762.00
-9.00 (-1.17%)
Aug 25, 2026, 3:30 PM JST
Koa Shoji Holdings Revenue
In the fiscal year ending June 30, 2026, Koa Shoji Holdings had annual revenue of 24.68B JPY with 6.06% growth. Koa Shoji Holdings had revenue of 6.34B in the quarter ending June 30, 2026, with 12.33% growth.
Revenue
24.68B
Revenue Growth
+6.06%
P/S Ratio
1.32
Revenue / Employee
81.18M
Employees
304
Market Cap
32.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 24.68B | 1.41B | 6.06% |
| Jun 30, 2025 | 23.27B | 1.14B | 5.13% |
| Jun 30, 2024 | 22.13B | 82.00M | 0.37% |
| Jun 30, 2023 | 22.05B | 1.70B | 8.35% |
| Jun 30, 2022 | 20.35B | 2.54B | 14.24% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KYORIN Pharmaceutical | 125.68B |
| Zeria Pharmaceutical | 91.12B |
| ASKA Pharmaceutical Holdings | 70.87B |
| Pharma Foods International | 67.00B |
| Fuso Pharmaceutical Industries,Ltd. | 62.85B |
| Fuji Pharma | 60.11B |
| Daito Pharmaceutical | 50.65B |
| Morishita Jintan | 12.82B |
Koa Shoji Holdings News
- 18 days ago - Koa Shoji Holdings Quarterly report: Q4 2026 - Filings
- 18 days ago - Koa Shoji Holdings Slides: Q4 2026 - Filings